Working across a variety of industries, including the healthcare, financial, and food and beverage industries, Price Wilson represents both targets and acquirers in connection with merger and acquisition activity and issuers in connection with debt and equity offerings. Price’s practice has encompassed deals worth nearly $8 billion to financing transactions valued at more than $800 million in aggregate.
Price’s practice involves:
Price’s experience also includes representing U.S. and foreign clients engaged in cross-border transactions.
American Health Lawyers Association (AHLA)
Representation of WellCare Health Plans, Inc., a government-focused managed care provider, in its merger with Centene Corporation (NYSE: CNC) for $17.3 billion
Represented WellCare Health Plans, Inc. (NYSE: WCG) in its definitive agreement to acquire Meridian.
We represented United Derm Partners, a portfolio company of Frazier Healthcare Partners, in its acquisition of two skincare and dermatology practices.
Represented Vivere Health in its sale to Prelude Fertility
Represented Evolent Health in its definitive agreement to acquire health plan management services organization from New Mexico Health Connections
Represented WellCare Health Plans in its definitive agreement to acquire Care1st Health Plan
Represented WellCare (NYSE: WCG) in its acquisition of Medicaid Assets of Phoenix Health Plan
Provided legal counsel to WellCare in its acquisition of Universal American Corp.
Represented Evolent Health, Inc (NYSE: EVH) in its acquisition of Aldera Holdings, Inc.
Represented Evolent Health in its acquisition of majority stake in Valence Health
IFLR1000 — Notable Practitioner
International Law Review Association — Editor